Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
第一作者:
Ming-Ming,He
第一单位:
Ming-Ming He, Dong-Sheng Zhang, Feng Wang, Zhi-Qiang Wang, Hui-Yan Luo, Chao Ren, Ying Jin, Dong-Liang Chen, Rui-Hua Xu, State Key Laboratory of Oncology in South China, Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong Province, China.
作者:
主题词
腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌胚抗原(Carcinoembryonic Antigen);化学疗法, 辅助(Chemotherapy, Adjuvant);卡方分布(Chi-Square Distribution);疾病恶化(Disease Progression);无病生存(Disease-Free Survival);女(雌)性(Female);胃切除术(Gastrectomy);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);病人遴选(Patient Selection);比例危险度模型(Proportional Hazards Models);回顾性研究(Retrospective Studies);危险因素(Risk Factors);胃肿瘤(Stomach Neoplasms);时间因素(Time Factors);治疗结果(Treatment Outcome);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53)
DOI
10.3748/wjg.v20.i1.264
PMID
24415881
发布时间
2021-10-21
- 浏览38

World journal of gastroenterology
2014年20卷1期
264-73页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文